Connective Tissue Growth Factor in Regulation of RhoA Mediated Cytoskeletal Tension Associated Osteogenesis of Mouse Adipose-Derived Stromal Cells by Xu, Yue et al.
Connective Tissue Growth Factor in Regulation of RhoA
Mediated Cytoskeletal Tension Associated Osteogenesis
of Mouse Adipose-Derived Stromal Cells
Yue Xu
1, Diane R. Wagner
1,2,3, Elena Bekerman
1, Michael Chiou
1, Aaron W. James
1, Dennis Carter
2,
Michael T. Longaker
1*
1Hagey Pediatric Regenerative Medicine Laboratory, Department of Surgery, Stanford University School of Medicine, Stanford, California, United States of America,
2Biomechanical Engineering Division, Department of Mechanical Engineering, Stanford University, Stanford, California, United States of America, 3Bioengineering
Graduate Program and Aerospace and Mechanical Engineering, University of Notre Dame, Notre Dame, Indiana, United States of America
Abstract
Background: Cytoskeletal tension is an intracellular mechanism through which cells convert a mechanical signal into a
biochemical response, including production of cytokines and activation of various signaling pathways.
Methods/Principal Findings: Adipose-derived stromal cells (ASCs) were allowed to spread into large cells by seeding them
at a low-density (1,250 cells/cm
2), which was observed to induce osteogenesis. Conversely, ASCs seeded at a high-density
(25,000 cells/cm
2) featured small cells that promoted adipogenesis. RhoA and actin filaments were altered by changes in cell
size. Blocking actin polymerization by Cytochalasin D influenced cytoskeletal tension and differentiation of ASCs. To
understand the potential regulatory mechanisms leading to actin cytoskeletal tension, cDNA microarray was performed on
large and small ASCs. Connective tissue growth factor (CTGF) was identified as a major regulator of osteogenesis associated
with RhoA mediated cytoskeletal tension. Subsequently, knock-down of CTGF by siRNA in ASCs inhibited this osteogenesis.
Conclusions/Significance: We conclude that CTGF is important in the regulation of cytoskeletal tension mediated ASC
osteogenic differentiation.
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Introduction
Connective tissue growth factor (CTGF, CCN2), a member of
the CCN family of proteins, is a cysteine-rich pro-adhesive
matricellular protein that plays an essential role in the formation
of blood vessels, bone, and connective tissue [1]. The angiogenic
inducer, 61 protein (Cyr61) and connective tissue growth factor
(CTGF) are structurally associated with secreted matrix cellular
proteins, and function in cell adhesion, migration, proliferation
and extracellular matrix (ECM) synthesis [2]. As an example of
context-dependent activity, functions of CTGF largely depend
on the interactions with other molecules in the microenviron-
ment [3]. Thus, instead of being a growth factor in the original
sense of the word, CTGF is better described as a modulator of
complex activities for other growth factors. In addition, CTGF
induces chondrogenesis and determines osteoblast differentia-
tion [4,5]. Previous studies have shown that CTGF is highly
expressed by osteoblasts, and CTGF null mice exhibit impaired
chondrocytic cell proliferation and angiogenesis resulting in
neonatal skeletal defects [6–9]. These observations suggest that
CTGF is important in bone and cartilage physiological events
and repair.
Studies reveal that tension in the actin cytoskeleton, which is
modulated by the RhoA/Rock signaling pathway, is a key player
in many cellular processes including proliferation, differentiation,
stabilization of cell-matrix adhesion and modulation of gene
expression. For example, diverse events such as branching
morphogenesis during lung development [10,11], and corneal
epithelial wound healing are both regulated by cytoskeletal tension
through the RhoA/Rock pathway [12]. In another recent study,
inhibition of the RhoA/Rock pathway in mesenchymal limb bud
cells altered chondrogenic gene expression, indicating that
cytoskeletal tension and chondrogenic differentiation are interre-
lated [13]. One mechanism by which cells regulate the mechanical
loads generated by their actin cytoskeleton is through cell
morphology; larger cells that are more spread contracted a flexible
substrate beneath them, while smaller cells did not. In bone
marrow-derived mesenchymal cells (BMSCs), cell shape and
cytoskeletal mechanics, mediated through the RhoA/Rock
signaling pathway, drove commitment to the osteogenic or
adipogenic lineages: large spread cells underwent osteogenesis
with high levels of active RhoA, while small unspread cells
underwent adipogenisis with limited RhoA activation [14,15].
Thus, cell size and its associated mechano-environment are key
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cellular signaling events that lead to the transition in lineage
commitment remain unaddressed.
Mesenchymal cells obtained from adipose tissue contain a large
number of progenitor cells with capabilities of osteo-, chondro-,
and adipogenic differentiation [16]. Moreover, an inverse
relationship between osteogenic and adipogenic commitment
within the whole adipose-derived stromal cell (ASC) progenitor
pool has been observed [17,18]. Studies using ASCs offer great
promise for skeletal tissue reconstitution and replacement [19,20].
Thus, understanding the mechanisms involved in the cellular
signaling of lineage commitment is an important step toward the
regulation of mesenchymal cell differentiation. In this study, we
manipulated the in vitro cell seeding densities of ASCs, resulting in
large and small cells with distinguished microenvironments
associated with actin cytoskeletal tension, and subsequently
explored the influence on osteogenic and adipogenic differenti-
ation of ASCs. Through the results of a gene array and siRNA
knock-down experiments, we determined that CTGF is highly
induced in large ASCs and is a pro-osteogenic effector that plays
an important role in RhoA mediated cytoskeletal tension-
associated osteogenesis.
Methods
Chemicals and Medium
Dulbecco’s Modified Eagles Medium (DMEM) and penicillin/
streptomycin were purchased from Invitrogen, Inc. (Carlsbad,
CA). Fetal bovine serum (FBS) was purchased from Omega
Scientific, Inc. (Tarzana, CA). All cell culture wares were
purchased from Corning Inc, (San Mateo, CA). Unless otherwise
specified all other chemicals were purchased from Sigma-Aldrich,
(St. Louis, MO). Recombinant CTGF was from ProSpec Protein
Specialists (Rehovot, Isreal).
ASC Harvesting and Seeding
All experiments were performed in accordance with Stanford
University Animal Care and Use Committee (IACUC) guidelines.
The IACUC protocol number for our study is 9999/7373. Mouse
adipose-derived stromal cells (ASCs) were isolated as described
previously [16]. ASCs were expanded in growth media contain-
ing DMEM (Mediatech, Herndon, VA), 10% FBS (Invitrogen,
Carlsbad, CA), 1% penicillin/streptomycin. Growth media were
changed every two days and cells were subcultured by trypsin/
EDTA. Passage one cells were used for the following experiments.
ASCs were seeded in 12-well dishes with different seeding
densities; a low density of 1,250 cells/cm
2; a medium density of
2,500 cells/cm
2, or a high density of 25,000 cells/cm
2. Crystal
violet staining was performed to show the microscopic cell
morphology and measure the cell sizes at different seeding
densities. Image J software was utilized to trace the cell shape
and calculate the cell size at different density seeding.
In Vitro proliferation
ASCs were seeded at low, medium and high densities as
described above. After attachment, cells were cultured in bipotent
medium containing both osteogenic and adipogenic factors. At
days 1, 3 and 7, cell proliferation was assessed via MTT (3-[4,5-
Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) assay
(n=3 wells per condition). Into each well, 50 ml of 5 mg/ml
MTT solution was added and allowed to incubate for three hours
at 37uC. The colored formazan product was dissolved in DMSO
and absorbance was measured at 570 nm.
In Vitro Osteogenic Differentiation
ASC osteogenesis was induced by treatment with basic
osteogenic differentiation medium (ODM) containing DMEM,
10% FBS, 100 mg/ml ascorbic acid, 10 mM b-glycerophosphate,
1% penicillin/streptomycin. The ODM was replenished every
three days. After one week of differentiation, early alkaline
phosphatase activity staining was performed and quantification of
alkaline phosphatase activity was assessed by normalizing to the
total protein quantity. After two weeks of osteogenic differentia-
tion, terminal osteogenic differentiation was evaluated by staining
the extracellular matrix (ECM) mineralization with Alizarin red S.
To inhibit cytoskeletal tension, cytochalasin D (0.5 ug/ml) and
Y-27632 (10 uM) were used to the differentiation medium block
the actin plymorlization and Rock/Rho pathways, respectively.
Recombinant CTGF (100 ng/ml) was supplemented to the
differentiation media in order to rescue the cytoskeletal tension.
To assess the effect of secreted factors from different density-
seeded cells, condition medium collected from low-, mediun- and
high-density-seeded ASCs was used. After attachment (approxi-
mately 12 hours post-seeding), media from each seeding density
was collected; 100 mg/ml ascorbic acid and 10 mM b-glycero-
phosphate was added to collected media. In a separate 12-well-
dish, in order to observe differences in differentiation with the use
of conditioned media, ASCs were seeded at a relatively higher
density of 20,000 cells/cm
2. Upon attachment, the same density-
seeded cells were treated with conditioned ODM generated by
different density seeding. After one week, early alkaline phospha-
tase activity staining and quantification were assessed to study the
effects of secret factors.
Staining and Quantification of Alkaline Phosphatase
Activity
After one week of osteogenic differentiation, medium was
removed and differentiated cells were washed twice with
phosphate buffered saline. Cells were then fixed with 60% acetone
and 40% Citrate working solution for 30 seconds at room
temperature. Following a brief rinse with deionized water, cells
were stained with a diazonium salt solution comprised of Fast
Violet B (0.024%) and 4% Naphthol AS-MX Phosphate Alkaline
Solution (Sigma Aldrich, St. Louis, MO) in the dark for 30 minutes
at room temperature. Positively stained cells were observed using
phase-contrast microscopy (Leica, San Jose, CA).
Alkaline phosphatase activity of differentiated cells was also
determined using a biochemical colorimetric assay kit (Sigma
Aldrich, St. Louis, MO) as described by the manufacturer. Briefly,
cells were washed with cold phosphate buffered saline. Cells were
scraped into a radioimmunoprecipitation assay (RIPA) buffer
(containing 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 5%
Glycerol, 1 mM EDTA, 1% NP-40, 0.1% SDS and 0.25% Na-
deoxycholate) and centrifuged. The enzymatic alkaline phospha-
tase activity in the supernatant of cell lysate was assayed by
measuring the p-nitrophenol formed from the enzymatic hydro-
lysis of p-nitrophenylphosphate, used as the substrate, at 405 nm.
In order to consider the protein turnover during the differentia-
tion, the quantity of alkaline phosphatase activity was normalized
to total protein, as measured by BCA protein assay reagent kit
(Pierce, Rockford, IL.). Experiments were performed in triplicate
wells and means and standard deviations were calculated. A
Student’s t-test was used to assess significance (*p#0.05).
Alizarin Red Staining and Quantification
After two weeks osteogenic differentiation, matrix mineraliza-
tion and calcium deposition were stained by Alizarin red. Cultured
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cells were washed briefly with deionized water, to minimize
potential for binding of Alizarin stain to PBS. As well, untreated
cells were washed with PBS in the same manner, so as to serve as
a control. Next, cells were fixed for 15 minutes in 100% ethanol
and stained with 0.2% Alizarin red S solution (PH 6.4) for 30
minutes. Stained cells were extensively washed with deionized
water to remove the nonspecific precipitation. The positive red
staining represents calcium deposits of matrix formation on the
mineralized cells. The matrix mineralization was quantified by
extraction of Alizarin red S staining with 100 mM cetylpyridi-
nium chloride solution and measuring the absorbance at 570 nm.
Experiments were performed in triplicate wells. Photographs were
obtained and presented for the analysis of late stage osteogenic
differentiation.
In vitro Adipogenesis and Assessment
ASCs were seeded at different densities as described above.
After attachment, adipogenic differentiation was induced with
adipogenic differentiation media (ADM) containing 10 mg/ml
insulin, 1 mM dexamethasone, 0.5 mM methylxanthine, and
200 mM indomethacin. ADM was replenished with growth media
containing 10 ug/ml insulin after three days of differentiation.
Adipogenic differentiation was assessed by staining with Oil Red
O at one week of differentiation. Briefly, cells were fixed in 10%
formalin/PBS for 30 minutes at room temperature and then
incubated in 60% Oil Red O solution (0.3% Oil Red O in
isopropanol) for 30 minutes in 37uC. Cells that developed lipid
accumulation were stained red. Images of adipogenic differenti-
ation were obtained microscopically. The quantification of Oil
Red O was performed by extracting the stain with isopropanol and
measuring the absorbance at 510 nm. Experiments were per-
formed in triplicate wells. A Student t-test was calculated to assess
the significance (*p#0.05).
The bipotent media, which was used to provide an environment
for both lineage differentiation, contained both osteo- and
adipogenic components [16].
Micropatterning: Stretching Cells in Defined Cell Sizes
In order to verify the expression of CTGF affected by cell size,
we applied micropatterning and managed seeding cells with
defined sizes [21]. Briefly, polydimethylsiloxane (PDMS) stamps
with different size of islands (ranging from 10 um,100 um in
diameter) were immersed in fibronectin at a concentration of
50 mg/ml in PBS for one hour, and allowed to dry. The stamps
were then placed in contact with the non-coated dish surface for
at least five seconds before being peeled off. The entire surface
was subsequently immersed in pluronic F-127 (0.2% w/v) in PBS
for three hours at room temperature in order to block the
nonprinting area [22]. Following a brief rinse with deionized
water, ASCs were seeded on the surface and allowed to settle on
the fibronectin (final concentration of 100 ug/ml in PBS) printed
area. After crystal violet staining, ASCs were observed to be
spread at sizes that corresponded to the printed areas. Only single
cells landed in the defined printed area were analyzed by
immunofluorescence.
Immunofluorescence
Cells were fixed with 4% paraformaldehyde/4% sucrose and
were blocked with a non-protein blocker (Dakocytomation,
Carpinteria, CA) for one hour at 37uC, and incubated with
primary antibodies (CTGF and RhoA were from Santa Cruz
Biotechnology, Santa Cruz, CA) for overnight at 37uC. Then, a
FITC- conjugated secondary antibody (Molecular Probes, Eugene,
OR) was applied to the cells for one hour at 37uC. Cells were then
mounted using Vectashield fluorescent mounting solution with
DAPI (Vector Labs, Burlinghame, CA) and analyzed by
fluorescence microscopy at 406 magnification (Carl Zeiss,
Thornwood, NY).
ASC morphology with RhoA/Rock inhibitors
ASCs were seeded at low or high density and treated with
cytochalasin D or Y-27632 as above. After 24 hours of treatment,
cells were fixed in a 4% paraformaldehyde/4% sucrose solution.
Phalloidin conjugated to rhodamine (Molecular Probes, Eugene
OR) was applied for one hour at 37uC to visualize F-actin. Cells
were then mounted using Vectashield fluorescent mounting
solution with DAPI (Vector Labs, Burlingame, CA) and visualized
by fluorescence microscopy at 406 magnification (Carl Zeiss,
Thornwood, NY).
RNA isolation and microarray hybridization
Total RNA was isolated using TRIzol solution (Invitrogen
TM)
according to manufacturer’s instructions. RNA from three
separate treatments of low and high seeding in growth media,
and low and high seeding in bipotent media were harvested for
microarray analysis. Fluorescently labeled DNA probes were
prepared from 50 to 70uC total RNA isolated from low density-
seeded and high density-seeded cells (Cy5-labeled) and Universal
Human Reference RNA (Stratagene, La Jolla, CA) (Cy3-labeled)
by reverse transcription using an Oligo dT primer 50-
TTTTTTTTTTTTTTT-30 (Qiagen, Valencia, CA) as described
[23]. Labeled probes from low and high density seeded cell RNA
and reference RNA were mixed and hybridized overnight at 65uC
to spotted cDNA microarrays with 41,126 elements (Stanford
Functional Genomics Facility, Stanford, CA). Microarray slides
were then washed to remove unbound probe and scanned with a
GenePix 4000B scanner (Axon Instruments, Inc., Union City,
CA).
Data processing and analysis
The acquired fluorescence intensities for each fluoroprobe were
analyzed with GenePix Pro 5.0 software (Axon Instruments, Inc.).
Spots of poor quality were removed from further analysis by visual
inspection. Data files containing fluorescence ratios were entered
into the Stanford Microarray Database (SMD) where biological
data were associated with fluorescence ratios and genes were
selected for further analysis [24]. Hierarchical clustering was
performed by first retrieving only spots with a signal intensity
.150% above background in either Cy5- or Cy3 channels in at
least 70% of the microarray experiments from SMD. We selected
clones whose expression levels varied at least threefold in all three
samples. The genes and arrays in the resulting data tables were
ordered by their patterns of gene expression using hierarchical
clustering analysis, and visualized using Treeview software
(http://rana.lbl.gov/EisenSoftware.htm) [25]. Genes with poten-
tially significant differential expression in ASCs from low- and
high-density seeding were identified using the Significance
Analysis of Microarrays (SAM) procedure, which computes a
two-sample T-statistic (e.g., for low-density-seeded cells vs. high-
density-seeded cells) for the normalized log ratios of gene
expression levels for each gene. We used a selection threshold
that gives a relatively low false discovery rate and identifies a
relatively high number of significant genes [26]. Array data is
publicly accessible at http://www.ncbi.nlm.nih.gov/geo/info/
linking.html, accession number GSE19924. All raw data has
been deposited in GEO data base.
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Total RNA was harvested from ASCs of low-density and high-
density seeding by using an RNAeasy Mini kit (Qiagen, Valencia,
CA), and treated with DNAse I (Ambion, Austin, TX). Reverse
transcription was performed using the Taqman
H Reverse Tran-
scription Kit from Applied Biosystems, Foster City, CA.
Quantitative real-time PCR was carried out using the Applied
Biosystems Prism 7900HT Sequence Detection System. The
Sequence for CTGF gene (NM_010217) primers is as following,
forward, 5-GGGCCTCTTCTGCGATTTC-3; reverse, 5-ATC-
CAGGCAAGTGCATTGGTA-3. Primers were first tested to
determine optimal concentrations, and products were run on a 2%
agarose gel to confirm the appropriate size and RNA integrity.
Gene expression values were normalized to 18S ribosomal RNA
quantity. All reactions were performed in triplicate. Representa-
tive graphs are shown with error bars indicating standard
deviation of the triplicate reactions. Multiple independent
experiments were conducted with similar trends. Statistical
analysis was performed using Student’s t test with *p#0.05
considered significant.
siRNA transfection
CTGF knock down experiments were performed by transfec-
tion of CTGF siRNA in ASCs, three pairs of the double strand
RNA were purchased from Ambion (Ambion, Austin, TX.).
According to the real time PCR results, the sequences of 5 -
GGUGAUAAAGCUAUGUAUUtt-3, 5-AAUACAUAGCUUU-
AUCACCtg-3 showed maximal knock-down efficiency of CTGF
in cells. ASCs seeded in low- and high-density were transfected
with CTGF siRNA (siCTGF), non-silencing siRNA (as a control)
(Invitrogen, Carlsbab, CA) or lipofectamine alone (LIPO) as
indicated above. Four hours of post-transfection, cells were washed
briefly with PBS and ODM was then changed to the transfected
cells. Meanwhile, RNA and protein were harvested from the cells
of 24 and 48 hours post-transfection for the evaluation of CTGF
knock-down. Transfection efficiency was determined by quantita-
tively assessing gene expression and protein expression of CTGF.
At 48 hours post-transfection, 80% of knock-down efficiency was
achieved shown by the expression of gene and protein.
Transfection was performed in multiple individual wells (N=6).
Experiments were repeated at least three times with different
isolation of the cells.
Statistical analysis
Means and standard deviations were calculated from numerical
data. In figures, bar graphs represent means and standard
deviation. Student t-test was performed to calculate the signif-
icance. *P#0.01 was considered to be significant.
Results
Different density seeding results in different sizes of ASCs
and influences osteogenesis and adipogenesis
To correlate osteogenesis and adipogenesis to ASC size, cells
were seeded in low, medium and high densities and induced to
osteogenic and adipogenic differentiation in either osteogenic
differentiation media (ODM) or adipogenic differentiation media
(ADM), respectively. Bipotent media, which contains both
osteogenic and adipogenic components, was used to concurrently
observe the bipotent potential of ASCs’ differentiation with
different seeding density [16]. ASC adipogenesis was assessed by
Oil Red O after one week of differentiation. Osteogenesis was
assessed at one week based on alkaline phosphatase activity
staining and quantification.
As demonstrated by crystal violet staining, ASCs spread into
large cells when they were seeded at a lower density (1,250 cells/
cm
2) and a medium density (2,500 cells/cm
2); conversely, when
ASCs were seeded at high density (25,000 cells/cm
2), they were
smaller in size microscopically (Figure 1A). To quantitatively
determine the relationship between the cell size and seeding
density, we utilized Image J software, and traced 10 different cells
from the pictures taken from low-, medium- and high- density
seeding. Average areas of the cells from different seeding density
were calculated separately. Cells seeded at low- and medium-
density were significantly larger in size as compared to the cells
seeded at high-density (*p#0.05).
Upon osteogenic induction, enhanced alkaline phosphatase
activity staining was observed in the low- and medium-density-
seeded, larger cells at one week of early osteogenesis (Figure 1B).
A quantitative alkaline phosphatase activity assay was performed
in order to consider the cell number presented in different density-
seeded samples. Data demonstrated significantly higher alkaline
phosphatase activity in the low- and medium-density-seeded cells
as compared to the high-density-seeded cells cultured in osteogenic
medium for one week (*p#0.05) (Figure 1C). Conversely, robust
adipogenesis was observed by Oil Red O staining in the high-
density-seeded, smaller cells after one week of adipogenic
differentiation (Figure 1B). The quantification of Oil Red O
demonstrated significant differences between the high- density-
seeded and low-/medium- density-seeded cells (*p#0.05)
(Figure 1C). Thus, enhanced osteogenesis was observed in larger
cells versus significant adipogenesis in the high-density-seeded,
smaller cells (*p#0.05). We found that Alizarin Red staining of
late stage mineralization correlated with the alkaline phosphatase
activity staining (data not shown). Similarly, when ASCs were
cultured in bipotent differentiation medium with different density
seeding, cell size affected osteogenesis and adipogenesis with the
same trend. Therefore, we observed that cell size was tightly
associated with the outcome of mesenchymal cell differentiation.
Increasing evidence suggests that mechanical deformation due
to shear forces or cell spreading plays an important role in
differentiation by influencing cell function. The hypothesis is that
growth factors and cytokines induced by such mechanical strain
act as modulators stimulating cell differentiation within the
microenvironment. To confirm the paracrine regulatory mecha-
nism, ASCs were seeded at the same density of 20,000 cells/cm
2.
Subsequently, conditioned media generated by low-, medium- and
high-density-seeded cells were used to induce osteogenesis in these
ASCs seeded at the same density. After differentiation, alkaline
phosphatase activity staining and quantification showed that large,
spreading cells secreted growth factors and cytokines in the
conditioned medium that contribute to osteogenic differentiation
in vitro when ASCs were seeded at the same density (Figure 1D).
These results demonstrated this mechanical stimulus regulated
mesenchymal cell differentiation via a paracrine mechanism.
Expression of Connective Tissue Growth Factor (CTGF)
Associated with Cell Size
To further determine which specific growth factors were
responsible for the observed paracrine effect, we performed
microarray assays on cells that were seeded at two distinct
densities (low and high). Twenty-four hours after seeding, RNA
was isolated from low-density-seeded larger cells and high-density-
seeded smaller cells. Based upon the data from microarray
analysis, the expression of connective tissue growth factor (CTGF)
was shown to be 17-fold higher in low-density-seeded, larger cells
(Figure S1 of microarray summary). To validate the results from
microarray, quantitative real-time PCR was performed on a
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PLoS ONE | www.plosone.org 4 June 2010 | Volume 5 | Issue 6 | e11279Figure 1. ASC seeding, morphology, cell size, osteogenic and adipogenic differentiation. A) Crystal violet staining of ASCs seeded at
different densities. Cells featured large morphology at a low density (L) seeding (1,250 cells/cm
2) and a medium density (M) seeding (2,500 cells/cm
2);
in contrast, ASCs were compressed into small cells at a high density (H) seeding (25,000 cells/cm
2). Calculated average cell sizes (n=10) by Image J
software are shown in the graph. The arbitrary number read by Image J for average area of low density seeding was 41752.4, medium density seeding
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significantly higher expression of CTGF in large cells as compared
to small cells (*p#0.05) (Figure 2A).
In order to more precisely determine the effect of cell size and
area, we applied a micropatterning technique to quantitatively
control the size of the cells. As described previously, the technique
allowed us to compare large cells (50–100 um) to small cells (10–
20 um) and evaluate CTGF expression. ASCs were allowed to
spread into different, defined sizes of fibronectin coated islands
(10 um,100 um in diameter) in growth media. To detect the
CTGF expression on larger and small cells, immunofluorescence
staining was performed and intense staining of CTGF was shown
on ASCs that were larger in size as compared to the small cells
(Figure 2B). In addition, we detected up-regulation of RhoA
(green) in low-density-seeded large cells, which provide an
evidence of tight connection between small GTPase Rho A and
CTGF. Interestingly, rhodamine phalloidin (red), which stained F-
actin in the cells, showed the distinguished ruffled actin filament
pattern in high-density-seeded small ASCs (Figure 2B). These
data indicated that cell size manipulated by the seeding density
resulted in an induction of CTGF as well as changes in actin
cytoskeletal dynamics in vitro.
To follow up with the immunofluorescence staining, a semi-
quantitative Western blot was performed on low-density-seeded
and high-density-seeded cells in growth medium and in the
presence of ODM. Data showed abundant CTGF protein
expression in low-density-seeded ASCs as compared to high-
density-seeded cells in both culture conditions (Figure 2C).
Similarly, RhoA, an important mediator of mechanical force and
cytoskeletal tension, was highly expressed in the low-density-
seeded larger cells. Although ODM appeared to induce a trace
amount of RhoA in high-density-seeded cells, the difference in
RhoA expression between low- and high- density seeded cells
remained substantial in the presence of ODM (Figure 2C). The
image of the Western blot was analyzed semi-quantitatively with
Image J software (Figure 2D). These data suggested that the cell
size and its associated mechanical environment induced up-
regulation of CTGF at both gene and protein levels, perhaps
modulated by actin cytoskeletal tension through the RhoA
pathway.
Deficiency of CTGF expression affects osteogenic
differentiation in ASC cells
Given that up-regulation of CTGF in large cells was associated
with osteogenic commitment in ASCs, we sought to assess the
effect of CTGF deficiency in cytoskeletal tension-associated
osteogenesis [27]. Utilizing a siRNA transfection in reduced-
serum medium (Invitrogen), CTGF gene and protein expression
was successfully knocked-down with approximately 80% efficiency
(*p#0.05) (Figure S2), as demonstrated by quantitative real-time
PCR and Western blot, respectively. These ASCs were then
differentiated in ODM at different seeding density. After one
week, alkaline phosphatase staining and quantification of enzy-
matic activity was significantly decreased, particularly in large,
low-density-seeded cells which expressed higher amounts of
CTGF (Figure 3A). After two weeks of osteogenic differentiation,
a significant decrease in mineralization was also observed by
Alizarin Red staining and quantification in CTGF siRNA
transfected cells as compared to the control transfected cells,
particularly in large cells (Figure 3B). The differences were
significant in low-density- and medium-density-seeded cells where
CTGF was highly expressed upon seeding (*p#0.05) (Figure 3B).
Thus, knock-down of CTGF, a multifunctional matricellular
protein, led to an insufficient signal transduction for mineralized
ECM formation. As a result, these cells exhibited impaired
osteogenesis.
Alteration of Osteogenesis and Adipogenesis by
Disruption of Cytoskeletal Tension with Rho/Rock
Inhibitors
Cell size as a result of plating density may affect mesenchymal
cell differentiation, which was observed to be a RhoA mediated
actin cytoskeletal tension associated function. Hence, we applied
cytochalasin D, chemical inhibitor of actin polymerization to block
the cytoskeletal tension; and Y-27632, an inhibitor of Rock, the
downstream target of RhoA. These two reagents were used to
block cytoskeletal tension at different stages and to examine their
possible roles in osteogenic and adipogenic differentiation. As
shown in Figure 4A, the morphologies of ASCs were dramatically
changed upon the treatments of cytochalasin D and Y-27632.
For example, cytochalasin D (0.5 ug/ml) disrupted cytoskeletal
filaments, resulting in small cells in all seeding densities; however,
Y-27632 (10 uM) blocked Rock, the downstream of RhoA,
only showed modest effect on ASC morphology. The profound
effect of cytochalasin D on cell size and morphology indicated that
the cytoskeletal tension was also altered by blocking RhoA
pathway.
Subsequently, we observed changes in ASC morphology with
RhoA/Rock inhibitors. Actin filaments were stained with
phalloidin conjugated to rhodamine (red) and counterstained with
DAPI for cell nuclei (blue). Cells treated with cytochalasin D were
small with disrupted actin structures in both low and high seeding
densities, while treatment with Y-27632 had only a modest effect
on ASC morphology (Figure 4B).
To explore the influence on differentiation, osteogenesis was
induced by treating different density-seeded cells with ODM in the
was 26565.7 and high density seeding is 5471.5. Graph shows the fold changes in cell size for low- and medium- density seeded ASCs as compared to
high-density seeded cells (*p#0.05). B) Scanned and microscopic images of cells plated at a low density (L) of 1,250 cells/cm
2, a medium density (M)
of 2,500 cells/cm
2, or a high density (H) of 25,000 cells/cm
2 cultured for one week in osteogenic differentiation media (ODM), adipogenic
differentiation media (ADM), or a bipotent media containing both osteogenic and adipogenic factors (bipotent). Cells in osteogenic media were
stained for alkaline phosphatase activity, cells in adipogenic media were stained with Oil Red O, and cells in bipotent media were stained for both.
Substantially higher alkaline phosphatase activity staining was shown in low density and medium density (large cells) seeding conditions in both
ODM and bipotent media. Conversely, high-density-seeded small cells committed to adipogenesis in both ADM and bipotent media. C) Quantitative
analysis of alkaline phosphatase activity (normalized to total protein content per well) for cells plated at low, medium and high density in ODM and
bipotent media and quantification of Oil Red O staining after one week in ADM. Low- and medium-density-seeded ASCs showed significantly higher
osteogenic differentiation potential in both ODM and bipotent media as compared to high-density-seeded ASCs after normalizing to the total
protein content (n=3 and *p#0.05). The extracted Oil Red O from high-density-seeded cells was significantly higher than the low- and medium-
density-seeded cells (n=3 and *p#0.05). D) Paracrine regulatory effect of osteogenesis by different density seeded cells. Although ASCs were seeded
at same density of 20,000 cells/well, alkaline phosphatase activity staining and quantification showed abundant staining in ASCs treated with
condition medium generated by low- and medium- density seeded cells as compared to high density-seeded cells (n=3 and *p#0.05).
doi:10.1371/journal.pone.0011279.g001
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previously observed, low-density-seeded cells underwent robust
osteogenesis as indicated by intense Alizarin Red staining whereas
the high-density-seeded cells showed no mineralization. Interest-
ingly, cytochalasin D treatment (0.5 ug/ml) in ODM completely
altered the osteogenic effect caused by cell size. However,
inhibition of downstream Rock by Y-27632 (10 uM) in ODM
did not affect this cell size related osteogenesis (Figure 5A).
Meanwhile, adipogenic differentiation was also assayed by using
adipogenic medium (ADM) with Rock/Rho inhibitors on different
density-seeded cells. We found that adipogenesis was completely
blocked by cytochalasin D (0.5 ug/ml) but not Y-27632 (10 uM)
(Figure 5B). Thus, these data suggested that cell size related
osteogenesis and adipogenesis are directly modulated by the RhoA
mediated action cytoskeletal tension.
Given that cytochalasin D robustly affected cell morphology
and differentiation (low density-seeded cells showed diminished
mineralization; high density- seeded cells showed increased
mineralization), we next explored how CTGF was involved in
this cytoskeletal tension associated function (Figure 5C). Quan-
titative real-time PCR demonstrated that the up-regulation of
CTGF in low density-seeded large cells was diminished by
treatment of cytochalasin D. This correlated with more mineral-
ization observed in large cells (Figure 5A). Conversely, cytocha-
Figure 2. Increased CTGF expression in low-density-seeded, large cells. A) Quantitative real-time PCR demonstrated significantly higher
levels of CTGF expression in low-density-seeded cells as compared to high-density-seeded cells (*p#0.05). Values were normalized to the expression
in high-density-seeded cells. B) Immunofluorescent images of CTGF staining. ASCs spread in a large microprinted (larger than 50 um in diameter) area
(a) showed intense staining of CTGF (green) as compared to ASCs spread in a small printed (smaller than 20 um in diameter) area (b). DAPI (blue)
counter staining indicates nuclei. RhoA and cytoskeletal filaments stained by rhodamine-conjugated phalloidin (staining for F-actin) at low (c) or high
(d) density. Cells were simultaneously stained for F-actin (red) and for RhoA with a FITC-conjugaed anti-RhoA (green) antibody and counterstained
with DAPI for cell nuclei (blue). ASCs seeded at low density displayed a higher expression of RhoA whereas ASCs seeded at high density showed more
overt actin ruffles within each cell. C) Western blot confirmed the changes in protein expression for both CTGF and RhoA. Abundant expression of
CTGF was shown in low-density-seeded ASCs after attachment in growth media (Growth); the difference remained significant when osteogenesis was
induced by ODM. In addition, the expression of cytoskeletal protein, RhoA was also higher in low-density-seeded cells in growth media; a minimal
amount of expression was detected in high density culture upon osteogenic induction by ODM (Low: low density seeding culture; High: high density
seeding culture). D) Quantitative analysis of scanned images of western blot. Graphs demonstrated a higher expression of CTGF and RhoA in low-
density-seeded cells (ODM: osteogenic differentiation media; Growth: growth media).
doi:10.1371/journal.pone.0011279.g002
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and there was a dramatic increase of CTGF in cytochalasin D
treated cells. On the other hand, the pattern of CTGF expression
remained unchanged with treatment of Rock inhibitor Y-27632
(high CTGF expression in large cells and low CTGF expression in
small cells) (Figure 5C). Thus, we concluded that the expression
of CTGF was altered by blocking RhoA mediated actin
cytoskeletal tension and the expression of CTGF contributes to
osteogenesis in ASCs.
Next, in order to determine the specific role of CTGF in
regulating the actin cytoskeletal tension associated osteogenesis, we
supplemented the recombinant CTGF (100 ng/ml) in ODM to
different density-seeded cells that are treated with and without
cytochalasin D. Data showed that recombinant CTGF could
partially rescue the osteogenesis modulated by the cytoskeletal
tension (Figure 5D).
Discussion
Strategies for directing mesenchymal stromal cell (MSC)
differentiation are not yet well defined. The emergent physical
microenvironment or niche where MSCs reside largely contributes
to the regulation of lineage commitment [28–30]. Primarily
isolated ASCs consist of osteo-, chondro- and adipogenic
progenitors which will commit to their specific lineages under
particular circumstances [31–33]. Recently, promising studies
have explored the broad applications in using ASCs as a cell
source for tissue engineering of cartilage and bone [34,35]. Thus,
Figure 3. Changes in ASC osteogenic differentiation with CTGF knock-down. A) Alkaline phosphatase staining and quantification. Low-
density-seeded ASCs transfected with CTGF-siRNA demonstrated decreased alkaline phosphatase activity compared to control (control siRNA-
transfected ASCs) low-density-seeded cells (n=3, *p#0.05). B) Alizarin Red staining and quantification. CTGF inhibition with siCTGF carried longer
term consequences in osteogenic differentiation. Alizarin red staining showed impaired late-stage osteogenesis in CTGF-deficient cells. Significant
differences were observed at both low- and medium-density-seeded ASCs after CTGF knockdown (n=3, *p#0.05).
doi:10.1371/journal.pone.0011279.g003
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translational research.
The transfer of mechanical strain results in activation of diverse
signaling cascades, culminating in the reprogramming of certain
gene expression and the production of growth factors and
cytokines [27]. Mcbeath et al. proposed that soluble factors
secreted from the MSCs were regulated by cell size associated
cytoskeletal tension and maintained tissue homeostasis [14].
However, little is known about which growth factors contribute
to the mechano-transactivation. Herein, utilizing in vitro manipu-
lation of cell size by seeding at different densities, we showed
dynamic differences in ASC morphology and actin cytoskeletal
tension demonstrated by RhoA kinase and F-actin expression
patterns. These differences were observed even though ASC
growth was largely unaffected (Figure S3). Subsequently,
differentiation potentials (osteogenesis and adipogenesis) were
influenced by cell size and their associated microenvironment.
Furthermore, we identified CTGF, a mechano-sensitive gene,
which provides unique binding domains for growth factors (i.e.
TGF-beta) and integrins, is involved in this cytoskeletal tension-
associated ASC differentiation.
CTGF gene expression is known to be induced through
mechanical stimulation and in particular through mechanical
stretch. For example, in vitro uniaxial tension increases the
expression of CTGF in chondrocytes, fibroblasts, and osteocytes
[36–38]. In vivo, CTGF is upregulated in stretched tendon and in
distraction osteogenesis of various cell types [39,40]. Additionally,
mechanical stretch stimulates osteogenic differentiation: stretched
BMSCs have greater osteogenic gene expression, increased
alkaline phosphatase activity, and enhanced mineralization
[41–44]. Studies have shown that diminishing CTGF expression
affects primarily the skeletal development as a result of impaired
skeletal proliferation and ECM production. Consistent with these
in vivo findings, we have demonstrated that CTGF deficiency in
vitro is sufficient to influence osteogenesis. Since CTGF does not
work independently, other growth factors, integrin family proteins
Figure 4. Changes in ASC morphology and differentiation with Rock/RhoA inhibitors. A) Microscopic images of cells plated at a low (L),
medium (M) or high density (H) with and without addition of cytochalasin D or Y-27632. Cytochalasin D disrupted cell tension (resulting in flat cells)
and significantly changed the morphologies of ASCs at all seeding densities. Y-27632 inhibited the downstream target Rock and did not lead to
changes in cell morphology in either low-, medium- or high- density conditions (406). B) Changes in ASC morphology with RhoA/Rock inhibitors.
Actin filaments were stained with phalloidin conjugated to rhodamine (red) and counterstained with DAPI for cell nuclei (blue). Cells treated with
cytochalasin D were small with disrupted actin structures in both low and high seeding densities, while treatment with Y-27632 had only a modest
effect on ASC morphology.
doi:10.1371/journal.pone.0011279.g004
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PLoS ONE | www.plosone.org 10 June 2010 | Volume 5 | Issue 6 | e11279and possible regulatory mechanisms linking this signaling cascade
remain to be investigated.
Most mechanical sensors are integrin family proteins linking
ECM proteins to intracellular signaling. Modulations of these ECM
proteins are coupled with intergrin-linked kinases such as small
GTPases [15]. The small GTPases of the Rho family are central in
mechano-transduction mediating the formation of focal complexes,
transducing signals intracellularly, and subsequently inducing
changes in gene expression, cellular shape and morphology [15].
In our study, blocking the arrangement of actin cytoskeletal tension
by cytochalasin D led to the reorganization of cytoskeletal proteins
that predominately influence cell tension and cell size in ASCs. The
rearrangement of actin cytoskeletal tension subsequently influenced
the lineage differentiation in these cells. Although inhibiting
ROCK, the down stream target of RhoA demonstrated a modest
change in ASC morphology, the differentiation capacity was
not significantly affected. Therefore, we concluded that RhoA
mediated actin cytoskeletal tension largely contributes to the
regulation of mesenchymal cell diffrentiation.
The molecular connection between the RhoA mediated actin
cytoskeletal tension and CTGF expression was revealed by
examining the expression of CTGF in cells after the treatment
of cytochalasin D. CTGF was significantly suppressed by the
disruption of RhoA mediated cytoskeletal tension. As a result of
effect, these cells were directed into alternative lineages. Given the
fact that recombinant CTGF partially restored this osteogenic
capability, we propose that multiple signaling cascades are
involved in this RhoA mediated cytoskeletal tension associated
osteogenesis and influence the cell fate decision in such
microenvironment [45,46]. Although we have demonstrated a
novel function of CTGF in our cell system, diverse signaling into
the molecular and cellular interaction between CTGF and Rho/
Rock pathway remains to be further elucidated.
Through our microarray analysis, multiple molecular signaling
pathways were identified to be potentially involved and complex
interdependent signaling networks are likely coordinated into this
cytoskeletal tension-associated regulation. In addition to up-
regulation of CTGF, our data showed that calponin-2, an actin-
binding protein implicated in cytoskeletal reorganization was
expressed five times higher in large cells [47,48]. Other studies
have demonstrated that calponin-2 expression was increased in
bone morphogenesis with retinoic acid-induced osteoblastic
differentiation [47]. Furthermore, colony stimulating factor-1
(CSF-1), tropomyosin-2 (TM-2) and SWI/SNF were all increased
over three fold in large cells. These genes are well described in
either bone remodeling or actin reorganization [49–51]. In
contrast, chemokine (C-X-C motif) ligand 12/SDF-1was highly
expressed in small cells seeded at a high density. This gene was
proved to be associated with hypoxia gradient response and
contributes to maintaining cells in undifferentiated stage [52,53].
These data highlighted the formation of cytoskeletal tension with
multiple interdependent signaling cascades.
Understanding in vitro models of micromechanical regulation will
advance the knowledge of how ASCs respond to various cellular
signaling. Fully comprehending these mechanisms can bridge the
chasm between developmental biology and tissue regeneration.
Supporting Information
Figure S1 Results of microarray analysis of up-regulated and
down-regulated genes in low-density-seeded cells. Table lists the
genes that show substantial expression differences in low-density-
seeded cells as compared to high-density-seeded cells. Positive fold
changes indicate up-regulation in low-density-seeded, large cells.
Negative values indicate down-regulation of the genes in the low-
density-seeded cells.
Found at: doi:10.1371/journal.pone.0011279.s001 (0.03 MB
DOC)
Figure S2 Efficiency of the CTGF knock-down by siRNA
transfection. A) Quantitative real-time PCR analysis after
48 hours of transfection. Approximately 80% of decrease in
CTGF gene expression was shown (*p,0.05). B) Western blot
analysis of CTGF protein expression. CTGF protein expression
was significantly decreased after CTGF SiRNA transfection.
Minimal amount of CTGF expression was detected after 48 hours
of transfection.
Found at: doi:10.1371/journal.pone.0011279.s002 (4.75 MB TIF)
Figure S3 MTT assay for cell proliferation analysis (n=3 wells
per condition). At day 7, cell proliferation had increased in all
density conditions with similar growth overtime.
Found at: doi:10.1371/journal.pone.0011279.s003 (7.23 MB TIF)
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